Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 2016

View Archived Issues

BioMed X and J&J to develop biofilm inhibitors for oral health applications

ChemoCentryx provides update on CCX-168

Verastem initiates phase I trial of defactinib, pembrolizumab and gemcitabine in pancreatic cancer

SolaranRx enters into CRADA with NCI to advance metastatic melanoma theranostic

Peregrine and NCCN establish research collaboration to advance development of bavituximab

C4 Therapeutics launches from Dana-Farber, enters collaboration with Roche

Principia advances two programs in clinic

ViiV Healthcare and Janssen to collaborate to develop rilpivirine and cabotegravir regimen

Gilead reports topline data from phase III studies of tenofovir alafenamide in chronic HBV

uniQure reports on low-dose cohort in phase I/II hemophilia B trial of AMT-060

X-Chem forms discovery collaboration with Sanofi

Checkpoint Therapeutics to obtain rights to Teva's oral PARP inhibitor

Aridis reports promising phase I data on Aerucin

Gruenenthal discloses CRAC blockers

NKTT-120 reduces iNKT cells in patients with sickle cell disease

Bayer Schering Pharma reports BRD4 inhibitors

The University of Montana presents SLC7A11 inhibitors

Johnson & Johnson Innovation discloses a plethora of new collaborations

XBiotech reports data from phase III European trial of Xilonix

AbbVie begins phase III program evaluating ABT-494 for rheumatoid arthritis

Gruenenthal and Akashi Therapeutics form joint drug development program for HT-100

PSMA-targeted ACCURIN shows promise for mCRPC

ImaginAb presents data on PSMA imaging agent for diagnosis of prostate cancer

PTC Therapeutics completes rolling NDA for Translarna, submits phase III data to EMA

FDA grants orphan drug designation to components of Immune Design's CMB-305

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...